parkinson's%20disease%20-and-%20parkinson's%20disease%20dementia
PARKINSON'S DISEASE & PARKINSON'S DISEASE DEMENTIA

Parkinson's disease is a progressive neurodegenerative disorder that is common, age-related and chronic.

It is caused by loss or degeneration of dopaminergic neurons in the substantia nigra of the midbrain.

Onset of symptoms and progression of the disease is gradual.

Motor signs and symptoms include resting tremor, rigidity, bradykinesia and postural instability.

Parkinson's disease dementia indicates loss of intellectual functions including memory, significant deterioration in the ability to carry out day-to-day activities and changes in social behavior are often noted.

Surgical Intervention

Neurosurgery

Pallidotomy

  • Unilateral pallidotomy has been shown to be effective but becomes unfavorable because of its irreversible nature

Deep Brain Stimulation (DBS)

  • Deep brain stimulation using implanted pulse generators in precise brain locations may be performed with specific indication
  • Both subthalamic nuclei (STN) and globus pallidus pars interna deep brain stimulation have shown efficacy in management of Parkinson's disease motor symptoms
  • Thalamic stimulation may be considered as an option in people with Parkinson's disease  who predominantly have severe disabling tremor and where subthalamic nuclei stimulation cannot be performed
  • Good candidates for deep brain stimulation include patients whose motor symptoms are not well controlled by medications or who cannot tolerate side effects of medications, and those who do not have significant active psychiatric or cognitive problems
  • Infection is the most commonly reported side effect of deep brain stimulation
Editor's Recommendations
Most Read Articles
Yen Yen Yip, 01 Sep 2012

For the first time, a randomized controlled trial has found the serotonin-norepinephrine reuptake inhibitor (SNRI) duloxetine to be effective against chronic neuropathic pain associated with taxane- or platinum-based chemotherapy. [ASCO 2012; abstract CRA 9013]

08 Nov 2017
In women with histories of sexual abuse, a low serum concentration of neuropeptide Y (NPY) is associated with psychogenic nonepileptic seizure (PNES), indicating its potential to be a future biomarker, a recent study suggests.